Manejo de SARC-CoV-2 en niños con trasplante de medula ósea

Epelbaum, C; Mónaco, A; Figueroa, C; Staciuk, R; Bologna, R; Rosanova, M T.
Med. infant ; 28(2): 132-138, Julio - Diciembre 2021. ilus
Artículo en Español | LILACS, UNISALUD, BINACIS | ID: biblio-1357628

Documentos relacionados

  1. Host Recovery from Respiratory Viral Infection.
  2. Haunting innate immune memories of COVID-19.
  3. IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.
  4. Multi-organ proteomic landscape of COVID-19 autopsies.
  5. Human Antibodies for Viral Infections.
  6. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
  7. Population immunity predicts evolutionary trajectories of SARS-CoV-2.
  8. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
  9. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
  10. Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.